Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer

NCT03045406 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1170

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: Apixaban
DRUG: Dalteparin

Sponsor

Fadoi Foundation, Italy

Collaborators

[object Object]